2015
DOI: 10.1164/rccm.201409-1698oc
|View full text |Cite
|
Sign up to set email alerts
|

The Utility of Preoperative Six-Minute-Walk Distance in Lung Transplantation

Abstract: Rationale: The use of 6-minute-walk distance (6MWD) as an indicator of exercise capacity to predict postoperative survival in lung transplantation has not previously been well studied.Objectives: To evaluate the association between 6MWD and postoperative survival following lung transplantation.Methods: Adult, first time, lung-only transplantations per the United Network for Organ Sharing database from May 2005 to December 2011 were analyzed. Kaplan-Meier methods and Cox proportional hazards modeling were used … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
59
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
6
3
1

Relationship

0
10

Authors

Journals

citations
Cited by 58 publications
(59 citation statements)
references
References 42 publications
0
59
0
Order By: Relevance
“…As they may attenuate disease progression, these antifibrotics may thus allow for valuable added time on the LTx waiting list. Next to FVC, 6MWT has also been shown to be a valid outcome measure, both in IPF, in whom the clinically important difference in 6MWT distance is reported to be 24–45 m [35] and in whom 6MWT is associated with changes in pulmonary function and quality-of-life [16]; and in patients awaiting LTx, in whom it is associated with post-transplant survival [17]. A reduction of the decline in 6MWT was also observed in treated patients compared to placebo in pooled analyses of IPF trials [35], which may partly explain why 6MWT overall remained relatively stable during treatment in our cohort, next to the obvious beneficial effects of cardio-pulmonary rehabilitation is some patients.…”
Section: Discussionmentioning
confidence: 99%
“…As they may attenuate disease progression, these antifibrotics may thus allow for valuable added time on the LTx waiting list. Next to FVC, 6MWT has also been shown to be a valid outcome measure, both in IPF, in whom the clinically important difference in 6MWT distance is reported to be 24–45 m [35] and in whom 6MWT is associated with changes in pulmonary function and quality-of-life [16]; and in patients awaiting LTx, in whom it is associated with post-transplant survival [17]. A reduction of the decline in 6MWT was also observed in treated patients compared to placebo in pooled analyses of IPF trials [35], which may partly explain why 6MWT overall remained relatively stable during treatment in our cohort, next to the obvious beneficial effects of cardio-pulmonary rehabilitation is some patients.…”
Section: Discussionmentioning
confidence: 99%
“…In addition, lower preoperative 6-minute-walk distance and serum albumin (potentially reflecting malnutrition) is associated with mortality after lung transplantation across disease types (59,60).…”
Section: Frailty In Pulmonary Diseasementioning
confidence: 99%
“…We are not aware of any studies to date that have measured physical performance and correlated these with outcomes in kidney transplant patients. In other solid organ transplant candidates, particularly in lung transplant, the six-minute walk test (6MWT)[21] has been used routinely in pre-transplant evaluations and has been shown to be a predictor of morbidity and mortality[22,23]. The 6MWT measures the distance that a patient can quickly walk on a flat, hard surface in a period of 6 min.…”
Section: Who Is An Appropriate Candidate?mentioning
confidence: 99%